These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 9484273)

  • 1. Investigation of lesions detected by mammography. The Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer. Canadian Association of Radiation Oncologists.
    CMAJ; 1998 Feb; 158 Suppl 3():S9-14. PubMed ID: 9484273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The palpable breast lump: information and recommendations to assist decision-making when a breast lump is detected. The Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer. Canadian Association of Radiation Oncologists.
    CMAJ; 1998 Feb; 158 Suppl 3():S3-8. PubMed ID: 9484272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The management of ductal carcinoma in situ (DCIS). The Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer. Canadian Association of Radiation Oncologists.
    CMAJ; 1998 Feb; 158 Suppl 3():S27-34. PubMed ID: 9484276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Follow-up after treatment for breast cancer. The Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer.
    CMAJ; 1998 Feb; 158 Suppl 3():S65-70. PubMed ID: 9484280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The management of chronic pain in patients with breast cancer. The Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer. Canadian Society of Palliative Care Physicians. Canadian Association of Radiation Oncologists.
    CMAJ; 1998 Feb; 158 Suppl 3():S71-81. PubMed ID: 9484281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preventive health care, 2001 update: screening mammography among women aged 40-49 years at average risk of breast cancer.
    Ringash J;
    CMAJ; 2001 Feb; 164(4):469-76. PubMed ID: 11233866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breast cancer, pregnancy, and breastfeeding.
    Helewa M; Lévesque P; Provencher D; Lea RH; Rosolowich V; Shapiro HM;
    J Obstet Gynaecol Can; 2002 Feb; 24(2):164-80; quiz 181-4. PubMed ID: 12196882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of abnormal screening mammograms.
    Shaw de Paredes E
    Cancer; 1994 Jul; 74(1 Suppl):342-9. PubMed ID: 8004606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening mammography in community practice: positive predictive value of abnormal findings and yield of follow-up diagnostic procedures.
    Brown ML; Houn F; Sickles EA; Kessler LG
    AJR Am J Roentgenol; 1995 Dec; 165(6):1373-7. PubMed ID: 7484568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. False-negative breast screening assessment: what lessons can we learn?
    Burrell HC; Evans AJ; Wilson AR; Pinder SE
    Clin Radiol; 2001 May; 56(5):385-8. PubMed ID: 11384136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic accuracy of commercial system for computer-assisted detection (CADx) as an adjunct to interpretation of mammograms.
    Menna S; Di Virgilio MR; Burke P; Frigerio A; Boglione E; Ciccarelli G; Di Filippo S; Garretti L
    Radiol Med; 2005 Oct; 110(4):334-40. PubMed ID: 16292240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coding mammograms using the classification "probably benign finding--short interval follow-up suggested".
    Caplan LS; Blackman D; Nadel M; Monticciolo DL
    AJR Am J Roentgenol; 1999 Feb; 172(2):339-42. PubMed ID: 9930778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NIH Consensus Statement. Breast cancer screening for women ages 40-49.
    NIH Consens Statement; 1997 Jan 21-23; 15(1):1-35. PubMed ID: 9267441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Positive predictive value of radiologic features in mammography and contribution of assessment procedures].
    Menna S; Marra V; Di Virgilio MR; Macchia G; Frigerio A
    Radiol Med; 1999 May; 97(5):349-53. PubMed ID: 10432965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changing emphasis in breast diagnosis: the surgeon's role in evaluating mammographic abnormalities.
    Sterns EE
    J Am Coll Surg; 1997 Mar; 184(3):297-302. PubMed ID: 9060928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening mammography: value in women 35-39 years old.
    Liberman L; Dershaw DD; Deutch BM; Thaler HT; Lippin BS
    AJR Am J Roentgenol; 1993 Jul; 161(1):53-6. PubMed ID: 8517320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of stereotactic biopsy in abnormal mammograms.
    Fajardo LL; DeAngelis GA
    Surg Oncol Clin N Am; 1997 Apr; 6(2):285-99. PubMed ID: 9115496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Guidelines for detection of breast cancer: an update on investigative methods. A report of the ad hoc committee on mammography of The Canadian Association of Radiologists.
    Hébert G; Carrier R; McFarlane DV; Charlebois S
    J Can Assoc Radiol; 1984 Mar; 35(1):6-13. PubMed ID: 6725372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. National Institutes of Health Consensus Development Conference Statement: breast cancer screening for women ages 40-49, January 21-23, 1997. National Institutes of Health Consensus Developmental Panel.
    J Natl Cancer Inst Monogr; 1997; (22):vii-xviii. PubMed ID: 9709265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Previous mammograms in patients with impalpable breast carcinoma: retrospective vs blinded interpretation. 1993 ARRS President's Award.
    Harvey JA; Fajardo LL; Innis CA
    AJR Am J Roentgenol; 1993 Dec; 161(6):1167-72. PubMed ID: 8249720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.